Indication

Complement hyperactivation angiopathic thrombosis protein losing enteropathy

Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (commonly referred to as CHAPLE syndrome or CD55 deficiency) is an ultra-rare, monogenic immune and gastrointestinal disorder inherited in an autosomal recessive pattern. Read more about Complement hyperactivation angiopathic thrombosis protein losing enteropathy

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Complement hyperactivation angiopathic thrombosis protein losing enteropathy therapies.

Showing 1–1 of 1 drugs

VEOPOZ (pozelimab-bbfg)

COMPLEMENT INHIBITORS·COMPLEMENT HYPERACTIVATION ANGIOPATHIC THROMBOSIS PROTEIN LOSING ENTEROPATHY
Regeneron Pharmaceuticals, Inc.
Filter & compare in the drug finder →Opens the drug finder with Complement hyperactivation angiopathic thrombosis protein losing enteropathy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complement hyperactivation angiopathic thrombosis protein losing enteropathy.

Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (commonly referred to as CHAPLE syndrome or CD55 deficiency) is an ultra-rare, monogenic immune and gastrointestinal disorder inherited in an autosomal recessive pattern.

The condition primarily manifests in infancy or early childhood and stems from loss-of-function mutations in the *CD55* gene (decay-accelerating factor), resulting in uncontrolled terminal complement cascade activation.

This complement dysregulation induces microvascular injury and intestinal lymphangiectasia, culminating in severe gastrointestinal protein loss, hypoalbuminemia, and peripheral edema.

Patients frequently experience chronic abdominal pain, malabsorption, malnutrition, recurrent infections due to hypogammaglobulinemia, and potentially life-threatening angiopathic thromboembolic occlusions.

Personalize your experience

Follow Complement hyperactivation angiopathic thrombosis protein losing enteropathy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it